Chinese Consulate Sought
Visit With Fentanyl Duo in Humbei Biotech Case
Now New Counsel
by
Matthew Russell Lee, Patreon Book
Substack
SDNY COURTHOUSE,
Sept 5 – The
day after
fentanyl and
China were
denounced by
all eight GOP
candidates in
their debate
in Milwaukee,
two defendants
were brought
shackled into
a federal
courtroom in
New York,
charged with
conspiracy to
important at
least 200
kilograms of
fentanyl
precursors.
Inner City
Press was
there.
Qingzhou Wang
had recently
changed
lawyers, from
a free Federal
Defender to
retained
counsel Daniel
Arshack.
Citing
the change of
counsel, U.S.
District Court
for the
Southern
District of
New York Judge
Paul G.
Gardephe set
another court
date in the
future,
October 24 at
10 am.
The
Assistant US
Attorney
described
trying to
brute-force
crack the
defendants'
cell phones,
two
each.
Also
charged in the
case is the
company Humbei
Amarvel
Biotech Co.
LTD, which is
unrepresented
in the docket
like a Last
Name Unknown
co-defendant
also known as
Er Yang or
Anita.
Back
on June 28 ,
counsel to
co-defendant
Yiyi Chen
asked Judge
Gardephe,
"I've spoken
to
representatives
of the Chinese
Consulate.
They're here
in court
today. They'd
like to know
if they can
have a brief
non-contact
visit with Ms.
Chen and the
co-defendant
if it's okay
with the Court
and the
marshals."
On
September 5,
now Yiyi Cheng
brought in as
retained
counsel
Shaoming Cheng
(whose only
SDNY case this
is). We'll
have more on
this.
The
case is US v.
Humbei Amarvel
Biotech Co.
LTD, et al.,
23-cr-302
(Gardephe)
More
details on
Substack here
***
Your
support means a lot. As little as $5 a month
helps keep us going and grants you access to
exclusive bonus material on our Patreon
page. Click
here to become a patron.
Feedback:
Editorial [at] innercitypress.com
SDNY Press Room 480, front cubicle
500 Pearl Street, NY NY 10007 USA
Mail: Box 20047, Dag
Hammarskjold Station NY NY 10017
Reporter's mobile (and weekends):
718-716-3540
Other, earlier Inner City Press are
listed here,
and some are available in the ProQuest
service, and now on Lexis-Nexis.
Copyright 2006-2023 Inner City
Press, Inc. To request reprint or other
permission, e-contact Editorial [at]
innercitypress.com
|